BMY
XNYSBristol-Myers Squibb Co.
Basic Materials · Pharmaceutical Preparations
$56.34
-0.15 (-0.27%)
15-min delayed
Drag to pan · Scroll to zoom · Hover for OHLC
Snapshot
Loading metrics…
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Employees
32,500
Country
US
IPO Date
1952-06-23
Recent News
Bristol-Myers Strikes $15.2 Billion China Drug Deal
Yahoo · 3h ago
Mann Partners Appoints Industry Veteran David Cohen to Advisory Board
Yahoo · 3h ago
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
Yahoo · 20h ago
BMS and Hengrui forge $15.2bn alliance for early-stage drugs
Yahoo · 1d ago
Bristol Myers Squibb signs $15.2B licensing deal with Hengrui
Yahoo · 1d ago
Bristol Myers Squibb Expands Pipeline With Hengrui Multi Billion Drug Alliance
Yahoo · 1d ago
Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
Yahoo · 1d ago
Bristol-Myers Squibb, Hengrui Pharma Sign Drug Development Deal Worth Up to $15.2 Billion
Yahoo · 1d ago
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.